Table 5.
Multidrug resistance profile of frequently isolate bacteria among HIV infected patients in the University of Gondar Teaching Hospital from March 1, 2013, to May 2, 2013.
| Bacterial species | Antimicrobial agents | Number of resistant isolates (%) |
|---|---|---|
| S. aureus | AMP and P | 2 (15.3) |
| AMP and SXT | 2 (15.3) | |
| AMP and MET | 1 (7.6) | |
| AMP, MET, and OXA | 1 (7.6) | |
| AMP, SXT, and P | 1 (7.6) | |
| AMP, SXT, E, and TE | 1 (7.6) | |
| AMP, SXT, E, TE, and CAF | 1 (7.6) | |
| AMP, SXT, MET, TE, P, and OXA | 1 (7.6) | |
| AMP, P, E, TE, MET, and OXA | 1 (7.6) | |
|
| ||
| CONS | AMP and SXT | 1 (12.5) |
| SXT and E | 1 (12.5) | |
| SXT and MET | 1 (12.5) | |
| SXT, MET, and E | 1 (12.5) | |
| SXT, MET, OXA, P, and TE | 1 (12.5) | |
| AMP, MET, CAF, CIP, E, P, SXT, and TE | 1 (12.5) | |
| AMP, MET, CAF, CN, E, OXA, P, SXT, and TE | 1 (12.5) | |
AMP: ampicillin; SXT: sulfamethoxazole/trimethoprim; CIP: ciprofloxacin; E: erythromycin; CN: gentamicin; MET: methicillin; P: penicillin; TE: tetracycline; CAF: chloramphenicol; OXA: oxacillin; CONS: coagulase negative staphylococci.